COMPARATIVE EFFECTIVENESS OF DENOSUMAB VERSUS ORAL BISPHOSPHONATES AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE US MEDICARE PROGRAM

被引：0
|
作者：
Curtis, J. [1 ]
机构：
[1] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL USA
来源：
AGING CLINICAL AND EXPERIMENTAL RESEARCH | 2023年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
SY6
引用
收藏
页码：S580 / S580
页数：1
相关论文
共 50 条
  • [31] COMPARATIVE EFFECTIVENESS OF OSTEOPOROSIS (OP) THERAPIES AMONG A POPULATION OF POSTMENOPAUSAL (PM) WOMEN IN THE UNITED STATES (US)
    Kim, M.
    Mcgrath, L.
    Pritchard, D.
    Samai, P.
    Lin, T.
    Stad, R.
    Spangler, L.
    Mcdermott, M.
    Bradbury, B.
    Brookhart, M.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S304 - S305
  • [32] Comparative Effectiveness of Osteoporosis (OP) Therapies Among a Population of Postmenopausal (PM) Women in the United States (US)
    Kim, Min
    McGrath, Leah J.
    Pritchard, David
    Samai, Peter
    Lin, Jay
    Stad, Robert Kees
    Spangler, Leslie
    McDermott, Michele
    Bradbury, Brian D.
    Brookhart, M. Alan
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1169 - 1170
  • [33] Switching to Denosumab or Bisphosphonates After Completion of Teriparatide Treatment in Women With Severe Postmenopausal Osteoporosis
    Kocjan, Tomaz
    Rajic, Antonela Sabati
    Janez, Andrej
    Vidmar, Gaj
    Orehek, Nina
    Marc, Janja
    Ostanek, Barbara
    ENDOCRINE PRACTICE, 2021, 27 (09) : 941 - 947
  • [34] COST-EFFECTIVENESS OF DENOSUMAB VERSUS ORAL BISPHOSPHONATES IN THE UNITED STATES FOR POST-MENOPAUSAL OSTEOPOROSIS (PMO)
    Parthan, A.
    Deflin, M. M.
    Yurgin, N.
    Huang, J.
    Taylor, D. C.
    VALUE IN HEALTH, 2012, 15 (04) : A38 - A38
  • [35] Osteoporosis diagnosis in postmenopausal women on oral bisphosphonates requiring dental extractions
    Diniz Freitas, M.
    Fernandez-Montenegro, P.
    Gonzalez-Mosquera, A.
    Vazquez, M.
    Fernandez-Feijoo, J.
    Diz-Dios, P.
    ORAL DISEASES, 2010, 16 (06) : 552 - 552
  • [36] Denosumab: A Unique Perspective on Adherence and Cost-effectiveness Compared With Oral Bisphosphonates in Osteoporosis Patients
    Morizio, Paige
    Burkhart, Jena I.
    Ozawa, Sachiko
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (10) : 1031 - 1041
  • [37] The comparative effect of teriparatide and denosumab on activins, follistatins, and inhibins in women with postmenopausal osteoporosis
    Anastasilakis, Athanasios D.
    Polyzos, Stergios A.
    Makras, Polyzois
    Savvidis, Matthaios
    Mantzoros, Christos S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 (09) : 1306 - 1314
  • [38] A Meta-Analysis of 4 Clinical Trials of Denosumab Compared with Bisphosphonates in Postmenopausal Women Previously Treated with Oral Bisphosphonates
    Miller, Paul D.
    Pannacciulli, N.
    Malouf, J.
    Singer, A.
    Czerwinski, E.
    Bone, H. G.
    Wang, C.
    Wagman, Rachel B.
    Brown, J. P.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [39] Cost-effectiveness of ibandronate injection IV in the treatment of UK women with postmenopausal osteoporosis who are intolerant to oral bisphosphonates
    Lynch, N. O.
    Earnshaw, S. R.
    Graham, C. N.
    Middelhoven, H.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S11 - S12
  • [40] Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis
    L. Karlsson
    J. Lundkvist
    E. Psachoulia
    M. Intorcia
    O. Ström
    Osteoporosis International, 2015, 26 : 2401 - 2411
12345